Nima Kokabi, MD

CIO 2021-34 Glass vs. Resin-based Y90 Radiation Segmentectomy of HCC: A Comparative Effectiveness, Safety and Dosimetry Study

Purpose: To evaluate the efficacy, safety, and dosimetry differences in patients with hepatocellular carcinoma (HCC) undergoing Yttrium-90 (Y90) radiation segmentectomy (RS) with glass-ba...

A. Villalobos ;

Zachary L. Bercu , MD;

Nima Kokabi , MD;

L. Ardnt ;

Boron Cheng , MD;

M. Loya ;

B. S. Majdalany ;

11/15/2021

Where Does IO Stand in the NCCN Guidelines: Panel Discussion

Nima Kokabi , MD;

Ahmed K. Abdel Aal , MD, PhD;

Nicholas Fidelman , MD;

Alda L. Tam , MD, FRCPC, MBA;

Nadine Abi-Jaoudeh , MD;

Daniel B. Brown , MD, FSIR;

02/16/2022

CIO 2022-22 Percutaneous Cryoablation versus Microwave Ablation of Renal Cell Carcinoma: A Comparative Study of Effectiveness and Safety

Winner of the 2022 Young Investigator Award. The authors evaluate differences in efficacy and safety between percutaneous cryoablation (CRA) and microwave ablation (MWA) of renal cell car...

A. Bode ;

A. Villalobos ;

H. Dabbous ;

M. Lilly ;

Zachary L. Bercu , MD;

Nima Kokabi , MD;

10/18/2022

Dosimetry of Hepatic Transarterial Yttrium-90 Radioembolization: What Interventional Oncologists Need to Know

Purpose: Transarterial yttrium-90 radioembolization (Y-90 RE) is a safe and effective treatment modality for both primary and metastatic hepatic malignancies. The therapeutic effect is de...

A. Villalobos ;

Nima Kokabi , MD;

W. Wagstaff ;

I. Sethi ;

B. David ;

G. Galt ;

D.M. Schuster ;

10/22/2019

Y-90 in Liver Metastatic Disease

Nima Kokabi, MD, Department of Radiology and Imaging Sciences, Assistant Professor, Emory University School of Medicine, presents the latest findings on Y-90 in liver metastatic disease. ...

Nima Kokabi , MD;

07/29/2021